MIRIPLA for intra-arterial injection 70mg (ミリプラ動注用70mg)

Land: Japan

Tungumál: enska

Heimild: すりの適正使用協議会 RAD-AR Council, Japan

Virkt innihaldsefni:

Miriplatin Hydrate

Fáanlegur frá:

Sumitomo Pharma Co.,Ltd.

INN (Alþjóðlegt nafn):

Miriplatin Hydrate

Lyfjaform:

injection

Upplýsingar fylgiseðill

Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 04/2019
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
MIRIPLA FOR INTRA-ARTERIAL INJECTION 70MG
ACTIVE INGREDIENT:
Miriplatin Hydrate
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine suppresses growth of cancer cells.
It is administered through hepatic artery and usually used to treat
liver cancer.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have thyroid disorder or liver disorder.
・If you are pregnant, possibly pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・In general, administer into the liver once a day.
・The treatment period with this medicine depends on your symptoms.
PRECAUTIONS WHILE TAKING THIS MEDICINE
・You may have a fever 1 week or later after administration.
POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE
The most commonly reported adverse reactions include fever,
nausea/vomiting, pain at the
injection site, loss of appetite, dull, chill, diarrhea, back pain,
headache, rash/eczema, cough,
abdominal pain, and constipation. If any of these symptoms occur,
consult with y